Source: SYS-CON MEDIA

Primm: Complex Generics Specialist Xbrane Acquires Italian Primm Pharma and Signs Iranian Pharmaceutical Deal

STOCKHOLM, October 14, 2015 /PRNewswire/ --read more

Read full article »

Primm's Competitors | Primm's News | Primm's Financials

Followers on Owler

Est. Annual Revenue

$25-100M

Est. Employees

100-250

CEO

Richard Stelluto

CEO Approval Rating

70/100

Primmbiotech provides manufacturing and marketing of biotech products that offers peptide synthesis, custom antibody service, DNA sequencing and more.